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Objective: To study the expression of caveolin-1 in colorectal adenocarcinoma tissues
and its correlation with microlymphatic vessel density (LMVD), and to investigate the
clinical pathological prognostic signiﬁcance of caveolin-1 and LMVD in patients with
colorectal cancer.
Methods: The expression of caveolin-1 and LMVD in 45 specimens of normal colo-
rectal tissues, and 90 specimens of colorectal adenocarcinoma tissues were detected by
immunohistochemistry technique. The correlation between their expression and the
clinicopathologic features was analyzed. Multivariable Cox regression was used to
analyze the association between the laboratory indices and overall survival time.
Results: The positive rates of caveolin-1 in colorectal adenocarcinoma tissues were
signiﬁcantly higher than those in normal colorectal tissues (P < 0.01). LMVD in colo-
rectal adenocarcinoma tissues were signiﬁcantly higher than those in normal colorectal
tissues (P < 0.01). Mean LMVD in group with caveolin-1 positive was signiﬁcantly
higher than in that with caveolin-1 negative. The median survival time was 26.7 months.
Cox regression analysis showed that the caveolin-1 expression, invation depth, lymph
node metastasis, TNM stage, liver metastasis and LMVD were independent risk factors of
overall survival time of patients with colorectal carcinoma.
Conclusions: Caveolin-1 may contribute to the lymphangiogenesis in the tumor. During
the occurrence and development of colorectal adenocarcinoma, there is a close rela-
tionship between the expression of caveolin-1 and lymphatic microvessel of tumor.
Caveolin-1 expression and microlymphatic vessel density are signiﬁcant prognostic value
of colorectal carcinoma.1. Introduction
Recently, more and more attention has been paid to caveolin-
1. Caveolin-1 is an important carcinogenic factor, and plays a
key role in the process of regulating cell signal transduction and
induction of proliferation, differentiation, migration and
apoptosis [1]. Lymphatic microvessel density (LMVD) can
reﬂect the progression of malignant tumor as important index
of micro lymphatics neonatal ability [2,3]. This study detected
the expression of caveolin-1 protein, and the average value of
LMVD in colorectal adenocarcinoma in order to analyze therelationship between caveolin-1, LMVD and prognosis of
colorectal adenocarcinoma.
2. Materials and methods
2.1. Clinical data
A total of 90 surgical specimens of colorectal adenocarci-
noma tissues and 45 specimens of normal colorectal tissues were
collected from July 2011 to July 2013. Cancer tissues were
excised from the center, and normal tissue were excised from
stump of the cut edge of the specimen at. All cases had no other
primary tumors, and received no neoadjuvant chemo-
radiotherapy, biological and immunotherapy. In colorectal
adenocarcinoma tissues, 57 cases were male, and 33 cases were
female, aged 36–74 years old, with average age as (55 ± 2.9)
years old; while in normal colorectal tissues, 28 cases were male,open access article under the CC BY-NC-ND
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age as (56 ± 2.1) years old. There was no statistical difference in
age, gender, etc between two groups (P > 0.05).
2.2. Methods and reagents
Mouse-anti-human monoclonal concentrated caveolin-1
antibody (cloning ab40278 R3-5G4) was from Abcam Com-
pany in Hong Kong; D2-40 was from Abnova Company in the
United States.
Formalin-ﬁxed parafﬁn-embedded tissue samples were cut
into sections (4 mm) with a microtome and dried overnight at
37 C on a silanised-slide. Dyeing slides were independently
observed and diagnosed under optical microscope. Samples
were deparafﬁnised in xylene at room temperature for 30 min,
rehydrated with graded ethanol and washed in phosphate-
buffered saline (PBS). The samples were then placed in
10 mm citrate buffer (pH 6.0) and boiled in a microwave for
10 min for epitope retrieval. Endogenous peroxidase activity
was quenched by incubating tissue sections in 3% H2O2 for
10 min. Caveolin-1 antibody were used overnight at 4 C at
dilutions of 1:150. The slides were washed and secondary
antibody was applied for 30 min after rinsing in PBS. The slides
were then washed and treated with the chromogen 3,3,-dia-
minobenzidine for 5 min, then rinsed in PBS, and counterstained
with hematoxylin, dehydrated in graded ethanols (80%, 85%,
90%, 95%, 100%), cleared in xylene and transparent for 5 min
and sealed by neutrality. PBS instead of ﬁrst antibody was
treated as negative control.
2.3. Criteria of positive result
The positive expression of caveolin was identiﬁed as yellow
and granular brown substance in cell nucleus. The immunore-
activities were graded as (−), (+), (++), and (+++) according to
the percentage of positive tumor cells identiﬁed: (−) represents
0 or less than 5% tumor cells; (+) represents 6%–25% tumor
cells; (++) represents 26%–50% tumor cells; and (+++) repre-Figure 1. Immunohistochemical staining of caveolin-1 protein and LMVD (IHC × 400).
A: Normal colorectal tissues; B: Colorectal adenocarcinoma tissues.
Figure 2. Overall survival curve.sents the strongest staining with more than 50% tumor cells
present. (+)–(+++) are considered to be positive.
D2-40 was marked in the membrane and cytoplasm of tumor
lymphatic endothelial cell and granular brown substance was
considered to be targeting cellular [4,5]. Firstly, 5 densely area
full of vascular (hot area) were selected under optical
microscope of 40 times, and then individual and cluster
endothelial cells with coloring were identiﬁed as theobservation area under optical microscope of 400 times,
ﬁnally, where the average number of targeting cellular was
counted as LMVD value.
2.4. Statistic analysis
The results were analyzed with SPSS 14.0. All enumeration
data was expressed as percentage, and measurement data was
expressed as mean ± SD. Multi-factor analysis of prognosis were
use by Cox Risk Model. The differences were considered to be
signiﬁcant at P < 0.05.
3. Results
3.1. Immunohistochemical staining of caveolin-1 protein
and LMVD
The positive expression rate of caveolin-1 in colorectal
adenocarcinoma tissues and normal colorectal tissues were
73.33% (66/90) and 11.11% (5/45), and the difference was
statistically signiﬁcant (P < 0.05). LMVD in colorectal adeno-
carcinoma tissues and in normal colorectal tissues was
18.25 ± 2.36 and 3.14 ± 1.58, and the differences was statistical
signiﬁcant (t = 32.00, P < 0.05) (Figure 1).
3.2. Relation of caveolin-1 protein and LMVD
Mean LMVD in group with caveolin-1 positive
(17.81 ± 2.15) was signiﬁcantly higher than in that with
caveolin-1 negative (6.15 ± 2.21), and the differences was sta-
tistical signiﬁcant (t = 21.42, P < 0.05).
3.3. Relation between caveolin-1 protein, LMVD and
pathological prognosis
The clinical data of 14 cases was lost and follow-up data of
76 cases was complete, including 42 male and 34 female cases,
Table 1
Multiple factor analysis of the prognosis of 76 cases with colorectal adenocarcinoma.
Risk factors RE SE SV P HR 95%CI
Tumor size 0.170 0.541 0.099 0.754 1.185 0.410–3.422
Histological types −0.024 0.363 0.004 0.947 0.976 0.479–1.989
Differentiation 0.162 0.334 0.234 0.629 1.175 0.611–2.261
Depth of invasion 2.405 0.810 8.823 0.003 11.083 2.266–54.198
Lymph node metastasis 1.555 0.611 6.482 0.011 4.736 1.430–15.682
TNM stage 2.514 0.810 9.627 0.002 12.353 2.524–60.453
Liver metastasis 2.079 0.811 6.574 0.010 8.000 1.632–39.212
Caveolin-1 3.209 0.675 22.601 <0.001 24.750 6.592–92.921
LMVD 1.239 0.615 4.057 0.044 3.453 1.034–11.532
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The median survival time was 26.7 months (8–56 months), and
1, 3 year survival rates were 91.60% and 75.15%, respectively
(Figure 2). Multi-factor analysis showed that caveolin-1, LMVD
value, invation depth, TNM stage, liver metastasis, lymph node
metastasis were independent risk factors (Table 1).
4. Discussion
Caveolin-1 gene as a member of caveolin family is located on
chromosome 7q31, containing 178 amino acid residues, which is
divided into two subtypes of a and b. The structure of caveolin-1
has a special domain, in which N-terminal amino acid contains
caveolin binding sequence similar to activation center of a va-
riety of signaling molecules [Caveolin-1 scaffolding domain
(CSD)]. CSD can specially combine a variety of cellular
signaling proteins, such as G-protein-subunits, Src, Fyn,
HA2Ras, EGF receptor, insulin receptor, eNOS, PKC, and so on
in order to play a role of targeted adjustment [6,7]. Its C-terminal
area containing Tyr14 phosphorylation, could specially bind to
Ab1, Frn, Src, and other tyrosine kinases, leading to the
phosphorylation, and thus induce a series of biochemical
reactions [8]. In addition, caveolin-1 can inhibit the system of
Ras/ERK, and MAPK/ERK, and induce cell excessive prolif-
eration and apoptosis, so as to promote their growth [9].
Caveolin-1 may promote the permanent withdrawal from the
cell cycle and induce apoptosis or necrosis.
In this study, high expression of caveolin-1 protein in colo-
rectal adenocarcinoma may be closely-related to invasion depth,
liver metastasis and lymph node metastasis, which was basically
consistent with studies of Yang et al. [10] and Xu et al. [11]. Further
research showed that the value of LMVD in groupwith caveolin-1
positive expression was signiﬁcantly higher than that in group
with caveolin-1 negative expression. Caveolin-1 may induce
lymphangiogenesis and promote tumor metastasis through the
lymphatic system in the colorectal cancer [12].
Furthermore, multiple factors analysis of prognosis showed
that the survival rate of patients with high LMVD value and high
caveolin-1 expression is signiﬁcantly lower than that with low
LMVD value and low caveolin-1 expression in the colorectal
cancer, which reveals that LMVD value and caveolin-1 have
important value in evaluating the prognosis of patients with
colorectal cancer. After colorectal cancer radical surgery, moni-
toring the tumor lymphatic could be used to predict the progress of
the tumor and the prognosis in order to provide valuable reference
index of treatment and postoperative follow-up.
Caveolin-1 and LMVD are independent prognosis indicators
for colorectal cancer, and the detection of caveolin-1 expression
and LMVD level helps to assess the malignant degree of tumor,so as to provide further guidelines for clinical diagnosis and
treatment. At the same time, the study of mechanism of inducing
tumor lymphangiogenesis and its gene targeting therapy may
lead to new inspiration and direction in the treatment for colo-
rectal cancer.
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